These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2983074)

  • 21. Endocrine factors in the treatment of prostatic cancer.
    Pierrepoint CG; Turkes AO; Walker KJ; Harper ME; Wilson DW; Peeling WB; Griffiths K
    Prog Clin Biol Res; 1985; 185A():51-72. PubMed ID: 3162177
    [No Abstract]   [Full Text] [Related]  

  • 22. The EORTC Phase III trials in prostatic cancer.
    Robinson MR; Smith PH; Macaluso MP; Sylvester R; de Voogt H
    Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132
    [No Abstract]   [Full Text] [Related]  

  • 23. Nonsteroidal antiestrogens and partial estrogens with prostatic tumor inhibiting activity.
    Schneider MR; Hartmann RW; Sinowatz F; Amselgruber W
    J Cancer Res Clin Oncol; 1986; 112(3):258-65. PubMed ID: 2946698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormonotherapy of so-called solid tumors].
    Cappelaere P
    Sem Hop; 1972 Jan; 48(4):279-82. PubMed ID: 4338349
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of reactivated prostatic cancer.
    Murphy G
    Vitam Horm; 1975; 33():399-415. PubMed ID: 779252
    [No Abstract]   [Full Text] [Related]  

  • 26. Lung metastases in prostatic carcinoma. Clinical significance.
    Varkarakis MJ; Winterberger AR; Gaeta J; Moore RH; Murphy GP
    Urology; 1974 Apr; 3(4):447-52. PubMed ID: 4856662
    [No Abstract]   [Full Text] [Related]  

  • 27. Androgen blockade and suppression for prostate carcinoma.
    Lancet; 1989 Oct; 2(8670):1020. PubMed ID: 2572747
    [No Abstract]   [Full Text] [Related]  

  • 28. Total androgen suppression in the management of prostatic cancer. A critical review.
    Schroeder FH
    Prog Clin Biol Res; 1985; 185A():307-17. PubMed ID: 3898133
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma testosterone in patients receiving diethylstilbestrol.
    Beck PH; McAnich JW; Goebel JL; Stutzman RE
    Urology; 1978 Feb; 11(2):157-60. PubMed ID: 628992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
    Lamberts SW; Uitterlinden P; de Jong FH
    Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prostatic cancer and its prognosis under Honvan treatment].
    Gaca A; Köhnlein HE; Köttgen H
    Med Welt; 1968 Apr; 15():961-7. PubMed ID: 5717752
    [No Abstract]   [Full Text] [Related]  

  • 32. [Trial of prostatic cancer treatment with estrogens associated with cyproterone].
    Hardy JC
    Acta Urol Belg; 1980 Jan; 48(1):110-2. PubMed ID: 7435344
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of advanced prostatic carcinoma with cyproterone acetate and orchiectomy--5-year follow-up.
    Giuliani L; Pescatore D; Giberti C; Martorana G; Natta G
    Eur Urol; 1980; 6(3):145-8. PubMed ID: 7371659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hormonal treatment benign prostatic hyperplasia. A review].
    Schoonees R; de Klerk JN
    S Afr Med J; 1972 Sep; 46(37):1337-9. PubMed ID: 4118059
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical effects of gonadotropin-releasing hormone analogue in metastatic carcinoma of prostate.
    Smith JA; Glode LM; Wettlaufer JN; Stein BS; Glass AG; Max DT; Anbar D; Jagst CL; Murphy GP
    Urology; 1985 Feb; 25(2):106-14. PubMed ID: 3918369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Status of the treatment of prostatic carcinoma--1964.
    Prout GR
    Proc Natl Cancer Conf; 1964; 5():309. PubMed ID: 5889426
    [No Abstract]   [Full Text] [Related]  

  • 37. Hormone therapy in cancer.
    Kennedy BJ
    Geriatrics; 1970 Oct; 25(10):106-12. PubMed ID: 4096937
    [No Abstract]   [Full Text] [Related]  

  • 38. Gestagens in the management of prostatic carcinoma.
    Szendröi Z
    Int Urol Nephrol; 1984; 16(4):327-35. PubMed ID: 6100181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of hormones on the growth of virus-transformed hamster prostatic tissue.
    Fraley EE; Paulson DF
    Surg Forum; 1968; 19():544-5. PubMed ID: 4304976
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hormonal therapy of prostatic carcinoma].
    Martz G
    Internist (Berl); 1968 Sep; 9(9):375-80. PubMed ID: 4918657
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.